Botox maker Allergan is about to launch clinical trials of a hair-growth treatment

[Winston]

The Phase 1 trial, scheduled to start this month, will focus on the safety of two formulations of bimatoprost, which is the active ingredient in Latisse.
This phase of the trials will include a total of about 28 patients — men with moderate male-pattern baldness and women with moderate female-pattern hair loss.


http://inyourface.ocregister.com/201...aldness/22858/